Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
CLAIRITY
Fifth Extension - Granted
Show more
Class 35: Providing information, advice, and data on radiology practice management
Class 42: Scientific and technological services, namely, scientific analysis of medical data and medical imaging in the field of breast health, including by means of artificial intelligence and deep learning in the fields of genomics, proteomics and radiomics
Class 44: Medical analysis services relating to the treatment of persons; providing information, advice, and data on medical imaging relating to breast health; medical analysis of medical data and medical imaging in the field of breast health, including by means of artificial intelligence and deep learning in the fields of genomics, proteomics and radiomics; consulting services in the field of medicine, namely, the assessment and prediction of breast health risks, patient engagement in the nature of diagnosis and treatment, consultations relating to predicted clinical outcomes
Class 35 – Advertising & retailClass 42 – Technology & SaaSClass 44 – Medical & beauty services
Status timeline
- 14 Jan 2022Application filedNew Application Entered
- 18 Oct 2022Assigned to an examining attorneyAssigned To Examiner
- 19 Oct 2022Office action issuedNon-Final Action Written
- 19 Apr 2023Response to office action filedTeas Response To Office Action Received
- 25 Apr 2023Response to office action filedTeas Response To Office Action Received
- 1 Aug 2023Approved for publicationApproved For Pub - Principal Register
- 5 Sep 2023Published for oppositionPublished For Opposition
- 31 Oct 2023Notice of allowance issued — statement of use requiredNoa Mailed - Sou Required From Applicant
- 23 Apr 2024Statement-of-use extension 1 grantedSou Extension 1 Granted
- 30 Oct 2024Statement-of-use extension 2 grantedSou Extension 2 Granted
- 30 Apr 2025Statement-of-use extension 3 grantedSou Extension 3 Granted
All 45 events
| 2026-08-08 | Case Assigned To Intent To Use Paralegal |
| 2026-08-08 | Sou Extension 5 Granted |
| 2026-08-08 | Notice Of Approval Of Extension Request E-Mailed |
| 2026-04-29 | Sou Teas Extension Received |
| 2026-04-29 | Sou Extension 5 Filed |
| 2025-10-31 | Notice Of Approval Of Extension Request E-Mailed |
| 2025-10-30 | Sou Teas Extension Received |
| 2025-10-30 | Sou Extension 4 Filed |
| 2025-10-30 | Sou Extension 4 Granted |
| 2025-06-09 | Teas Revoke/App/Change Addr Of Atty/Dom Rep Received |
| 2025-06-09 | Attorney/Dom.rep.revoked And/Or Appointed |
| 2025-06-09 | Teas Change Of Correspondence Received |
| 2025-05-01 | Notice Of Approval Of Extension Request E-Mailed |
| 2025-04-30 | Sou Teas Extension Received |
| 2025-04-30 | Sou Extension 3 Filed |
| 2025-04-30 | Sou Extension 3 Granted |
| 2024-10-30 | Sou Teas Extension Received |
| 2024-10-30 | Sou Extension 2 Filed |
| 2024-10-30 | Sou Extension 2 Granted |
| 2024-10-30 | Notice Of Approval Of Extension Request E-Mailed |
| 2024-04-24 | Notice Of Approval Of Extension Request E-Mailed |
| 2024-04-23 | Sou Teas Extension Received |
| 2024-04-23 | Sou Extension 1 Filed |
| 2024-04-23 | Sou Extension 1 Granted |
| 2023-10-31 | Noa Mailed - Sou Required From Applicant |
| 2023-09-05 | Published For Opposition |
| 2023-09-05 | Official Gazette Publication Confirmation E-Mailed |
| 2023-08-16 | Notification Of Notice Of Publication E-Mailed |
| 2023-08-01 | Correspondence Received In Law Office |
| 2023-08-01 | Teas/Email Correspondence Entered |
| 2023-08-01 | Approved For Pub - Principal Register |
| 2023-04-25 | Teas Response To Office Action Received |
| 2023-04-24 | Examiners Amendment And/Or Priority Action - Completed |
| 2023-04-24 | Combined Examiner's Amendment/Priority Action Automatic Entry |
| 2023-04-24 | Examiner's Amendment/Priority Action E-Mailed |
| 2023-04-24 | Notification Of Examiner's Amendment/Priority Action E-Mailed |
| 2023-04-20 | Teas/Email Correspondence Entered |
| 2023-04-19 | Teas Response To Office Action Received |
| 2023-04-19 | Correspondence Received In Law Office |
| 2022-10-19 | Non-Final Action Written |
| 2022-10-19 | Non-Final Action E-Mailed |
| 2022-10-19 | Notification Of Non-Final Action E-Mailed |
| 2022-10-18 | Assigned To Examiner |
| 2022-01-18 | New Application Office Supplied Data Entered |
| 2022-01-14 | New Application Entered |
Goods & services by class
Class 35 Advertising & retail
Providing information, advice, and data on radiology practice management
Class 42 Technology & SaaS
Scientific and technological services, namely, scientific analysis of medical data and medical imaging in the field of breast health, including by means of artificial intelligence and deep learning in the fields of genomics, proteomics and radiomics
Class 44 Medical & beauty services
Medical analysis services relating to the treatment of persons; providing information, advice, and data on medical imaging relating to breast health; medical analysis of medical data and medical imaging in the field of breast health, including by means of artificial intelligence and deep learning in the fields of genomics, proteomics and radiomics; consulting services in the field of medicine, namely, the assessment and prediction of breast health risks, patient engagement in the nature of diagnosis and treatment, consultations relating to predicted clinical outcomes
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 8 Aug 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.